A
BSX icon

Astrantus’s Boston Scientific BSX Stock Holding History

Astrantus’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$478K Buy
+10,800
New +$468K 0.8% 8

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Astrantus's BSX Position: Q1 2022 in Review

Astrantus opened a new position in Boston Scientific (BSX) in Q1 2022: 10,800 shares worth $478K. The stake represents 0.8% of the portfolio and ranks #8 among its holdings.

904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Astrantus held 10,800 shares of Boston Scientific worth $478K as of Q1 2022.
  • Boston Scientific was a new Astrantus position in Q1 2022.
  • Boston Scientific made up 0.8% of Astrantus's portfolio in Q1 2022, its #8 holding.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.